Reports
Sale
Global Smart Insulin Pens Market Size, Price, Forecast: By Products: Smart Insulin Pens, Adaptors for Conventional Pens, Disposable, Reusable; By Type: First Generation Pens, Second Generation Pens; By Connectivity Type: Bluetooth, USB; By Application: Type 1 Diabetes, Type 2 Diabetes; Regional Analysis; Supplier Landscape; 2024-2032
Global Smart Insulin Pens Market Outlook
The global smart insulin pens market size was valued at USD 83.86 million in 2023, driven by the increasing prevalence of diabetes across the globe. The market is anticipated to grow at a CAGR of 12.3% during the forecast period of 2024-2032 to achieve a value of USD 237.45 million by 2032.
Smart Insulin Pens: Introduction
Smart insulin pens are used by people with diabetes to inject insulin. These easy-to-use pens are different from conventional insulin injections. These smart pens use sensors and internal memory to track and record insulin doses for a patient. Insulin pens are built so that they can also be paired with devices such as smart phone applications for better accessibility of the data that has been recorded.
Some of the insulin pens even have setups to set reminders and alerts for administering insulin. Users who use these features are better able to maintain healthy diabetes management and follow their insulin schedule. Some of the insulin pens even have setups to set reminders and alerts for administering insulin. Users who use these features are better able to maintain healthy diabetes management and follow their insulin schedule.
Global Smart Insulin Pens Market Analysis
The trends in the market include the increasing investments that are being made by the manufacturers in research and development to introduce new features and functionalities in smart insulin pens to the users. Due to the smart connectivity feature of these smart pens, developments have been undergoing to make them more connectivity efficient and connect them with even more devices instead of just smart phones, watches among others driving the global smart insulin pens market expansion. Data management from the data generated by the smart insulin pens has been a trend running in the market. The data that is generated by these pens can be used by doctors to provide a better and personalized conclusion current status of health. This data can be used by the users to optimize their treatment and management plans.
Global Smart Insulin Pens Market Segmentations
Market Breakup by Products
- Smart Insulin Pens
- Adaptors for Conventional Pens
- Disposable
- Reusable
Market Breakup by Type
- First Generation Pens
- Second Generation Pens
Market Breakup by Connectivity Type
- Bluetooth
- USB
Market Breakup by Application
- Type 1 Diabetes
- Type 2 Diabetes
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Smart Insulin Pens Market Overview
The global market for smart insulin pens is experiencing an evident growth due to the increasing prevalence of diabetes and the rising demand for more effective and user-friendly insulin delivery systems. Smart inulin pens are positioned to play a crucial role in promoting treatment adherence, improving diabetes management results, and ultimately improving the quality of life for people with diabetes as the industry continues to develop.
Additionally, the increased technological advancements in smart insulin pens, including connectivity with smartphone apps, data integration, and insulin dose calculation algorithms, are further propelling the smart insulin pens market growth. The integration of smart insulin pens with digital health platforms and electronic health records is also capable of enhancing the efficiency of diabetes management. Furthermore, the increasing emphasis on personalized medicine and patient-centered care is driving the demand for smart insulin pens in the market due to the customized insulin delivery they provide.
Overall, the smart insulin pens market development is likely to be driven by the diabetic population increase, technology advances, and the need for better diabetes management becomes paramount. The need for improved insulin management and enhanced glycaemic control, among diabetes patients, is driving the adoption of smart insulin pens by healthcare professionals and patients. These devices include useful features, such as dose tracking, dose memory, and reminders, that helps patients follow their insulin regimens and better manage their blood sugar levels.
Smart Insulin Pens Market: Competitor Landscape
The key features of the market report include market landscape, patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Emperra GmbH
- Medtronic Plc
- Novo Nordisk
- Pendiq
- Sanofi FA
- Berlin-Chemie AG
- Bigfoot Biomedical
- Digital Medics Pty Ltd.
- Eli Lilly and Company
- Jiangsu Deflu Medical Device Co. Ltd.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products |
|
| Breakup by Type |
|
| Breakup by Connectivity Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Smart Insulin Pens Market Overview
3.1 Global Smart Insulin Pens Market Historical Value (2017-2023)
3.2 Global Smart Insulin Pens Market Forecast Value (2024-2032)
4 Global Smart Insulin Pens Market Landscape
4.1 Smart Insulin Pens: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Smart Insulin Pens: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Connectivity type
4.2.3 Analysis by Applications
5 Global Smart Insulin Pens Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Smart Insulin Pens Market Segmentation
6.1 Global Smart Insulin Pens Market by Products
6.1.1 Market Overview
6.1.2 Smart Insulin Pens
6.1.3 Adaptors for Conventional Pens
6.1.4 Disposable
6.1.5 Reusable
6.2 Global Smart Insulin Pens Market by Type
6.2.1 Market Overview
6.2.2 First Generation Pens
6.2.3 Second Generation Pens
6.3 Global Smart Insulin Pens Market by Connectivity Type
6.3.1 Market Overview
6.3.2 Bluetooth
6.3.3 USB
6.4 Global Smart Insulin Pens Market by Application
6.4.1 Market Overview
6.4.2 Type 1 Diabetes
6.4.3 Type 2 Diabetes
6.5 Global Smart Insulin Pens Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Smart Insulin Pens Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Smart Insulin Pens Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Smart Insulin Pens Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Smart Insulin Pens Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Smart Insulin Pens Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Emperra GmbH
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Medtronic Plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Novo Nordisk
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Pendiq
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Sanofi FA
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Berlin-Chemie AG
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Bigfoot Biomedical
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Digital Medics Pty Ltd.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Eli Lilly and Company
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Jiangsu Deflu Medical Device Co. Ltd.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 83.86 million in 2023, driven by increased advancement in insulin devices.
The market size is anticipated to grow at a CAGR of 12.3% during the forecast period of 2024-2032, and likely to reach a market value of USD 237.45 million by 2032.
The rising incidence of diabetes, along with the affordability and accessibility of the therapeutic products and services, are the major factors aiding the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The components in the market include smart insulin pens, adaptors for conventional pens disposable, and reusable.
The types of insulin pens include first generation and second-generation pens.
The applications can be for type 1 diabetes and type 2 diabetes.
The different connectivity types in the market includes Bluetooth and USB.
Key players involved in the market are Medtronic Plc, Novo Nordisk, Pendiq, Sanofi FA, Berlin-Chemie AG, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company., Jiangsu Deflu Medical Device Co. Ltd., and Emperra GmbH.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER